Canadian Manufacturing

New Jersey manufacturer partnering with Kinaxis to increase supply chain efficiency

Alvogen chose the Kinaxis RapidResponse® platform, concurrent planning and a suite of applications to deliver the connected and collaborative supply chain it needs.

April 27, 2021  by CM Staff

OTTAWA — On Apr. 27, Kinaxis® Inc., announced that Alvogen, a global pharmaceutical company, has selected Kinaxis to create a more connected supply chain to better manage growth. With Kinaxis, Alvogen will have end-to-end visibility across the entire supply chain and have the ability to manage the network via an integrated planning platform.

Based in Morristown, New Jersey, Alvogen focuses on developing, manufacturing and selling generic, brand, over the counter (OTC) and biosimilar products for patients around the world. Alvogen currently has a commercial footprint in more than 20 markets, including China, Hong Kong, Iceland, India, Luxembourg, Malaysia, Malta, the United States, Philippines, Singapore, South Korea, Taiwan, Thailand and Vietnam.

“Alvogen’s purpose as an organization is to make people’s lives better by producing high-quality medicines and making them more accessible to those who might otherwise not be able to afford them,” said Stephen Fecho, U.S. Vice President, Supply Chain & Third Party Operations at Alvogen. “To bring this purpose to life, we need a supply chain that offers complete visibility, and enables us to be more responsive to global change and disruption. We selected Kinaxis RapidResponse because of its ability to deliver a proven integrated planning platform with the ability to quickly realize business benefits.”

When searching for a partner, Alvogen chose the Kinaxis RapidResponse® platform, concurrent planning and a suite of applications to deliver the connected and collaborative supply chain it needs to scale its business. The always-on capabilities of RapidResponse gives Alvogen the confidence in its decision-making while improving the transparency within the supply chain.

Advertisment

“Life sciences and pharmaceutical supply chains have never been so important, yet have also never been faced with such disruption, making transparency and agility vital to success,” said John Sicard, CEO, Kinaxis. “We are thrilled to have been selected by Alvogen to help them take a truly innovative and future-looking approach to their supply chain. By enabling end-to-end visibility and concurrent planning, we help Alvogen get their life-saving medications to customers across the globe in the most streamlined, efficient manner possible – a game-changer for its customers.”